Provided by Tiger Fintech (Singapore) Pte. Ltd.

Azenta

33.23
+0.38001.16%
Post-market: 33.230.00000.00%16:20 EDT
Volume:542.75K
Turnover:18.00M
Market Cap:1.52B
PE:-24.39
High:33.48
Open:32.55
Low:31.83
Close:32.85
Loading ...

Company Profile

Company Name:
Azenta
Exchange:
NASDAQ
Establishment Date:
1978
Employees:
3000
Office Location:
200 Summit Drive,6th Floor,Burlington,Massachusetts,United States
Zip Code:
01803
Fax:
- -
Introduction:
Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold storage solutions, consumables and instruments, controlled rate thawing devices, and temperature-controlled storage and transportation solutions. This segment also provides sample management solutions, such as consumable vials and tubes, polymerase chain reaction, plates, instruments for supporting workflows, and informatics. The Life Sciences Services segment provides genomic services, that includes gene sequencing and gene synthesis services; and sample repository solutions, such as on-site and off-site sample storage, cold chain logistics, sample transport and collection relocation, bio-processing solutions, disaster recovery and business continuity, and biospecimen procurement services, as well as project management and consulting services for genomic analysis and the management and care of biological samples used in pharmaceutical, biotech, healthcare, clinical, and academic research, and development sectors. It serves a range of life science customers, including pharmaceutical companies, biotechnology companies, biorepositories, and research institutes. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.

Directors

Name
Position
John P. Marotta
Director, President and Chief Executive Officer
Alan Joseph Malus
Independent Director
Dipal Doshi
Independent Director
Erica J. McLaughlin
Independent Director
Martin D. Madaus
Independent Director
Quentin G. Koffey
Independent Director
Robyn C. Davis
Independent Director
Tina S. Nova
Independent Director
William L. Cornog
Independent Director

Shareholders

Name
Position
John P. Marotta
Director, President and Chief Executive Officer
Ephraim Starr
Senior Vice President, General Counsel and Secretary
Ginger Zhou
Senior Vice President and General Manager, Multi-Omics
Herman Cueto
Executive Vice President and Chief Financial Officer
Lawrence Y. Lin
Executive Vice President and Chief Financial Officer
Olga Pirogova
Senior Vice President and Chief Human Resources Officer
Frank E. Casal
Chiarman of the Board